Navigation Links

DISCLAIMER

The information displayed herein is provided in good faith, but we make no
guarantees about the completeness, accuracy, timeliness, availability,
accessibility, merchantability, or fitness for any particular purpose of
any of the information. The Bio-Medicine is not responsible for any
errors or omissions, which may occur in the information provided.


Any reference made by Bio-Medicine in this web site to any company
or any other entity, or to their services or products, is not an
endorsement nor should it imply any such endorsement of the quality or
fitness of purpose of that company or entity, or its services or products.


The Bio-Medicine disclaims all liability and responsibility for any
loss, damage, or inconvenience whatsoever or howsoever suffered, directly
or indirectly by any person as a result of their use of this web site and
of any information and contact details supplied. Any person proposing to
use or rely on any of the contact details should first satisfy themselves
of the completeness and accuracy of those contact details and any other
information displayed with or in relation to them on this web site.
Any access of this web site by the user is entirely at the user’s own risk
and the Bio-Medicine shall not be responsible for the propagation
of computer worms or viruses transmitted from the site.
By accessing this web site you agree with these conditions and agree to
hold harmless the operators and maintainers of the web site and their
agents and partners.
(Date:7/10/2020)... FALLS CHURCH, Va. (PRWEB) , ... July 08, ... ... , The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, ... product may need a comparability study, but what is the most effective way ...
(Date:7/2/2020)... ... July 01, 2020 , ... ... 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host ... by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, ...
(Date:7/1/2020)... Calif. (PRWEB) , ... July 01, 2020 , ... ... on building awareness and solutions for glioblastoma—the most common and aggressive adult brain ... Lisa Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s initiatives ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... HMI Performance Incentives’ ... Creative Awards, was a charitable push put together to help spread positivity in ... during the pandemic, HMI asked individuals in its audience to share stories, answering ...
(Date:7/18/2020)... ... ... Nader Sanai, M.D., director of the Ivy Brain Tumor Center at Barrow Neurological Institute ... (#GBMDay) on July 22, 2020 to raise national consciousness. , Glioblastoma Awareness Day ... common and aggressive form of brain cancer. It also honors those who have been ...
(Date:7/18/2020)... ... ... When the federal government extended the Paycheck Protection Program from June 30th ... to obtain a PPP loan. But the biggest obstacle often may be that many ... are eligible. , While 4.9 million companies obtained potentially forgivable loans through PPP, ...
(Date:7/10/2020)... ANGELES (PRWEB) , ... July 10, 2020 , ... ... that is proud to announce its newest offering, Liposuction 360 . The ... the addition to its comprehensive catalog of plastic surgeries and cosmetic procedures is ...
(Date:7/10/2020)... ... July 09, 2020 , ... NeoTract, a wholly owned ... of urology, today announced that Miguel Mercado, M.D., Texas Urology Specialists in Tomball, ... that Dr. Mercado has achieved a high level of training and experience with ...
Breaking Medicine News(10 mins):